ELAVL1 and cancer: Our deconvolution analysis suggests HuR may act as a pan-cancer negative regulator of tumor immune infiltration, and combining HuR-focused scRNA-seq with functional assays could identify lineage-specific RNA targets driving immune evasion, thereby advancing our mechanistic understanding of HuR’s role in tumor immunomodulation.